In this webcast, Ben McGraw reviews how medical device and diagnostics companies are using Spotfire for in stream safety review, risk-benefit assessments, post marketing surveillance, data management and clinical operations.
In this webcast, Ben McGraw of TIBCO Spotfire and Duncan Hall of Triumph Consultancy Services walk through an implementation methodology and discuss the organizational challenges involved in adopting a metrics based approach to running clinical trials.
"A product like Spotfire can help you visualize that very easily"
Business intelligence has evolved to a point where its appeal has spread to a broadening range of organisations. Melbourne-based Walter & Eliza Hall Institute of Medical Research (WEHI) was established in 1916 to engage in immunology research, and today also works in research for cancer and chronic inflammatory diseases.
Dana Farber: "Visual Analytics Provides Insight Into Cancer Vaccine Clinical Trials" by Drug Discovery & Development
TIBCO Spotfire provides Dana-Farber Cancer Institute with unprecedented insight into cancer vaccine clinical trials.
Dana-Farber Cancer Institute Gains Unprecedented Insight into Cancer Vaccine Clinical Trials with TIBCO Spotfire
“Spotfire quickly gave us a visual analysis of major trends and main clusters of activity, highlighting neglected areas and graphically pointing out the glaring need of many of these cancers for additional vaccine development.” Vladimir Brusic, Dana-Farber CVC’s Director of Bioinformatics
European Molecular Biology Laboratory Uses TIBCO Spotfire to Help Identify and Develop Chemical Compounds In Academic Screening Facility
EMBL’s Chemical Biology Core Facility – a joint venture between the European Molecular Biology Laboratory , the German Cancer Research Center(DKFZ) and Heidelberg University – successfully deploys Spotfire software’s interactive and robust analytics capabilities.
This is an abbreviated version of the more detailed whitepaper that explores how companies are meeting analytics challenges around the growing number of clinical trials and a wide array of study designs.
Pharmaceutical firm places DecisionSite® at the core of its microarray gene expression analysis platform.
TIBCO Spotfire expert Michael O’Connell, discusses key challenges faced by clinical development organizations, and how they’re getting solved.
In this webcast, Dr. Eskouhie Tchaparian demonstrates how TIBCO Spotfire RealTime StatMiner is used to measure relative quantification of transcription levels and select different gene expression levels in a step-by-step workflow.
GlaxoSmithKline Streamlines the Design, Analysis and Reporting of Clinical Trial Data with Clinical Graphics Solution from Insightful
The clinical graphics solution developed by Insightful is being utilized by GlaxoSmithKline (GSK) to streamline the design, analysis and reporting of clinical trial data. By using the clinical graphics solution, GSK’s Biomedical Data Sciences statistical community is facilitating better scientific analysis and interpretation, and enabling more effective communication across functional areas.
Spotfire provides a standardized company-wide safety review tool for rapid data visualization and analysis of adverse events, lab data, operational metrics, protocol deviations and custom and target reviews.
In this webcast, Dr. Mark Demesmaeker shares how European Life Science companies are using Spotfire for self-service data discovery in areas such as in-stream safety review, data quality assessment, protocol adherence, site reporting and patient enrollment.
The trend toward evidence-based decision-making is taking root in commercial, non-profit and public sector organizations. Driven by increased competition due to changing business models, deregulation or, in some cases, increased regulation in the form of new compliance requirements, organizations in all industries and of all sizes are turning to business intelligence (BI) and data warehousing (DW) technologies and services to either automate or support decision-making processes.
While Spotfire has been and will continue to be a powerful industry independent analytical, modeling, and visualization tool, a key strength in the life science industry is its ability to work effectively with most other core industry applications.
This IDC Health Insights Perspective highlights the use of TIBCO Spotfire in the life sciences as the de facto end user interface of choice for the strategic assessment of clinical data.
Identify New Licensing Opportunities and Perform Asset Scouting and Benchmarking with TIBCO Spotfire and Relay TM’s BD Live!
In this webcast, Relay Technology Management demonstrates how the "BD Live!" platform integrates with Spotfire to aggregate and visualize both structured and unstructured data, enabling in stronger portfolio optimization and benchmarking for life science industries.
Infinity Pharmaceuticals wanted to increase the quality and speed of its analytical decision making in the discovery of new drug candidates. Spotfire® DecisionSite™ provided the tools to achieve its goals and reduce the crucial “time to next experiment.”
When consultants from Innovative Analytics help pharmaceutical companies track down the cause of unexpected clinical trial results, they use Spotfire® DecisionSite™ to quickly focus attention on critical data points.
Motorola Life Sciences selects Insightful’s analytic technology to manufacture reliable high-quality biochips for genomics and expression data mining
High-performance analytic software technology combined with Motorola’s Six Sigma semiconductor manufacturing legacy optimizes manufacturing processes, geometrically increases product sensitivity, repeatability, and miniaturization and provides an everincreasing level of customer satisfaction. Product yield and quality has increased substantially since the application of Insightful’s advanced analytical software mixed with a unique application of techniques gleaned from Motorola’s experience in semiconductor engineering.
Novartis Uses TIBCO Spotfire for Exploratory Data Analysis and Safety Assessment in Preclinical and Clinical Studies
Spotfire is used for safety data assessment and interactive data exploration in preclinical and clinical studies at Novartis. Workflows based on Spotfire are a substantial step forward from traditional manual processes which include reworking of data in multiple iterations between stakeholder communities.
In this webcast, Ben McGraw of TIBCO Spotfire and Franziska Zitt of Roche demonstrate how the Spotfire platform has optimized Roche's clinical data collection, storage, and trial data review.
Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization to catalyze communication and collaboration among scientists.
At Pfizer, S-PLUS was deployed using StatServer software and a company-wide Intranet for data analysis and FDA reporting. "Historically, our company submitted hundreds of lengthy reports including 30 to 40 pages of graphs to the FDA. Each researcher was responsible for preparing their own reports and as a company we did not have access to standardized analytics. We were looking for a leading software solution that could deliver the powerful analytics and graphic capabilities we needed to our employee's desktops," says John Twist, Section Director, PDS Planning and Statistics. "We selected StatServer because it provided its cutting-edge analytics, browser compatibility and integration with complementary Microsoft Office reporting packages."
TIBCO Spotfire is the premier data discovery and analytics platform, which provides powerful capabilities for our customers, such as dimension-free data exploration through interactive visualizations, and data mashup to quickly combine disparate data to gain insights masked by data silos or aggregations.
Putting Analytics to Work for Faster, Smarter Insights (Audio, 30 mins) By Brian Gentile, TIBCO Analytics
Inside Analysis hosts a discussion between Brian Gentile of TIBCO Analytics and industry veteran, Eric Kavanagh, CEO and senior analyst with The Bloor Group about how businesses are gathering faster, richer analytics on their organization and applying it to generate insights and influence decision-making. Topics covered include the starting point for organizations to adopt analytics today, the ways analytics are being applied across different industries, and the power of visualization to understand not only static reports, but data in motion to predict and change the course of business and yield better results.
In this webcast, Ben McGraw of TIBCO Spotfire and Ed Acker of Teradata explore the topics of disease prevalence and drug prevalence by analyzing 53 million rows of patient profile data in Spotfire's visualization-based data discovery environment.
Relay Technology Management Develops Biopharma Industry’s First Unified Solution for Real-time Business Intelligence and Data Visualization
Leveraging TIBCO Spotfire® data discovery as the front-end and Attivio’s unified information access technology in the back-end, Relay TM developed Business Development Live (BD Live!), a real-time business intelligence and data visualization solution for life sciences professionals. BD Live! aggregates and instantly visualizes structured and unstructured data from more than 27 million data points in real-time, representing a comprehensive list of scientific and business literature, technology transfer data, and clinical trial data.
The number of clinical trials underway each year has been increasing steadily, worldwide. With a broad range of study designs, varying data collection methods and time points, efficient data analysis in clinical development has become more important than ever. This whitepaper discusses how companies are meeting the challenges with new analytics approaches.
Surromed Inc. is a pioneering biomarker enabled drug discovery and development company and they needed an analysis workflow application for biomarker discovery. With S-PLUS Server and Spotfire DecisionSite they were allowed greater access to analytics and information which improved the quality of decision-making enterprise-wide.
In order to reduce costs, maintain market share and increase revenue, pharmaceutical, biotechnology and medical device companies face increasing pressure to bring new drugs to market in the shortest possible time. Spotfire analytics addresses these challenges by enabling actionable decisions that enhance patient safety, streamline operations and enable faster product launches leading to better medical outcomes for the patients and financial outcomes for the life science industry.
This whitepaper outlines How TIBCO Spotfire analytics can guide you down the critical path to greater efficiency in the development of new drugs.
At Tularik, Spotfire® DecisionSite™ helps clinical pre-marketing risk analysts get a jump on spotting adverse event risks—before they adversely affect the bottom line.
“We selected S+ArrayAnalyzer because it offered our research team the flexibility and extensibility to customize an analytic-rich solution to meet the unique needs of our diverse research team,” said Dr. Markus Loeffler.
DecisionSite™ for Functional Genomics®’ data integration capabilities have opened up new analytic opportunities for UW’s biomedical researchers.
Drug discovery and development can be time consuming and expensive. Each year, the global pharmaceutical industry spends at least $10 billion on clinical trials. To counter this expense, next-generation statistical software provides pharmaceutical scientists with the tools they need to discover hidden knowledge buried in data collected during clinical trials. The use of software tools with powerful graphical and modeling capabilities, such as S-PLUS, result in better and faster drug development.
“Previously, it was difficult to identify trends in the large amounts of screening data generated, including systematic issues. With TIBCO Spotfire, we can visualize our results in a real-time dashboard, identify and exclude the systematic errors as they occur, and run repeat samples as required. We’ve reduced Hit Discovery data processing by more than 65 percent.” Dr. Kurt Lackovic, Senior Research Officer, Walter + Eliza Hall Institute of Medical Research